Researchers gain new insights into how the isotope astatine-211 interacts with resins commonly used to purify the isotope for therapeutic use Targeted Alpha Therapy (TAT) is one of the most powerful ...
Hosted on MSN
Targeted alpha therapy using astatine shows promise in thyroid cancer resistant to conventional treatment
A new targeted alpha therapy is showing promise for patients whose thyroid cancer no longer responds to radioactive iodine, the standard beta-emitting treatment. In a first-in-human study, ...
Naya Therapeutics Inc. is expanding its hepatocellular carcinoma pipeline with the addition of NY-700, a first-in-class GPC3-targeted Astatine-211 (211At) α radioimmunotherapy aiming to address ...
NAYA's European Hub to Accelerate Clinical Development of its Astatine-211 Targeted Alpha Therapies and Multispecific ...
Astatine‑211 is increasingly recognized as the alpha emitter of choice for targeted radiotherapeutics. Its pure alpha emission results in high‑energy, short‑range cytotoxicity that selectively ...
Reston, VA (December 4, 2025)--A new targeted alpha therapy is showing promise for patients whose thyroid cancer no longer responds to radioactive iodine, the standard beta-emitting treatment. In a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback